Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03106428
Title A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Research Site Los Angeles California 90095 United States Details
Research Site Denver Colorado 80218 United States Details
Research Site Atlanta Georgia 30322 United States Details
Research Site Chicago Illinois 60611 United States Details
Research Site Boston Massachusetts 02114 United States Details
Research Site Saint Louis Missouri 63110 United States Details
Research Site New York New York 10065 United States Details
Research Site Greer South Carolina 29650 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site San Antonio Texas 78229 United States Details
Research Site Pierre Benite 69495 France Details
Research Site Villejuif 94805 France Details
Research Site Seoul 03080 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field